The first Bio-Rad Laboratories trade was made in Q1 2013.
Since then Chuck Royce bought shares five more times and sold shares on 30 occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in Bio-Rad Laboratories anymore.
Avg closing price
Price range
Sold -22.8 Thousand shares
Q2 2024
Avg closing price
$290.85
Price range
$268.26
-
$339.48
Increased shares by 126.1% (+12.7 Thousand shares)
Q1 2024
Avg closing price
$328.84
Price range
$304.11
-
$351.99
Sold 66.7% shares (-20.2 Thousand shares)
Q4 2023
Avg closing price
$313.43
Price range
$269.37
-
$365.04
New holding (+30.3 Thousand shares)
Q3 2023
Avg closing price
$385.83
Price range
$350.25
-
$422.63
Sold -6.33 Thousand shares
Q2 2021
Avg closing price
$608.62
Price range
$576.64
-
$649.04
Sold 56.7% shares (-8.3 Thousand shares)
Q4 2020
Avg closing price
$569.50
Price range
$510.68
-
$643.45
Sold 14.6% shares (-2.5 Thousand shares)
Q3 2020
Avg closing price
$506.50
Price range
$454.43
-
$535.60
Sold 42.6% shares (-12.7 Thousand shares)
Q2 2020
Avg closing price
$441.30
Price range
$334.87
-
$493.06
Sold 5.0% shares (-1.57 Thousand shares)
Q1 2020
Avg closing price
$367.68
Price range
$320.01
-
$409.07
Sold 53.2% shares (-35.7 Thousand shares)
Q4 2019
Avg closing price
$352.55
Price range
$319.73
-
$374.20
Sold 5.6% shares (-3.95 Thousand shares)
Q3 2019
Avg closing price
$326.21
Price range
$304.55
-
$345.24
Increased shares by 0.4% (+300 shares)
Q2 2019
Avg closing price
$299.43
Price range
$286.93
-
$312.59
Sold 15.8% shares (-13.3 Thousand shares)
Q4 2018
Avg closing price
$268.31
Price range
$220.10
-
$309.00
Sold 7.1% shares (-6.39 Thousand shares)
Q3 2018
Avg closing price
$310.39
Price range
$289.28
-
$326.15
Sold 3.3% shares (-3.07 Thousand shares)
Q2 2018
Avg closing price
$276.12
Price range
$244.10
-
$303.88
Increased shares by 15.1% (+12.2 Thousand shares)
Q1 2018